Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideBSXBoston Scientific
FinDog View：Bullish
| Metric | ABBV | BSX |
|---|
| Close | 262.51 | 43.91 |
| Market Cap | $464B | $63.6B |
| 1M | +4.87% | −14.62% |
| P/E (TTM) | 73.7 | 17.3 |
| Forward P/E | 16.8 | 13.4 |
| P/E 5-Yr Percentile | 51 | 0 |
| P/S | 7.2 | 3.0 |
| P/B | — | 2.6 |
| Dividend Yield | 4.47% | — |
| Latest Quarter Revenue | $17.0B | $5.4B |
| Revenue YoY | +10.2% | +7.5% |
| Gross Margin | 74.7% | 70.7% |
| Latest Quarter EPS | 2.03 | 0.61 |
| Avg Post-Earnings Move | ±1.7% | ±1.5% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.91% | — |
| 90-Day Net Insider Buying | −$8.2M | +$9.5M |
ABBV · Revenue, Last 8 Quarters ($B)
BSX · Revenue, Last 8 Quarters ($B)
